1 Cash-Producing Stock to Research Further and 2 Facing Challenges
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that excels at turning cash into shareholder value and two that may struggle to keep up.
Two Stocks to Sell:
NXP Semiconductors (NXPI)
Trailing 12-Month Free Cash Flow Margin: 21.3%
Spun off from Dutch electronics giant Philips in 2006, NXP Semiconductors (NASDAQ: NXPI) is a designer and manufacturer of chips used in autos, industrial manufacturing, mobile devices, and communications infrastructure.
Why Is NXPI Not Exciting?
- Sales were flat over the last two years, indicating it’s failed to expand this cycle
- Estimated sales growth of 15.4% for the next 12 months is soft and implies weaker demand
NXP Semiconductors’s stock price of $223.28 implies a valuation ratio of 13.4x forward P/E. If you’re considering NXPI for your portfolio, see our FREE research report to learn more.
Pediatrix Medical Group (MD)
Trailing 12-Month Free Cash Flow Margin: 11.7%
With a network of approximately 2,620 affiliated physicians caring for some of the most vulnerable patients, Pediatrix Medical Group (NYSE:MD) provides specialized physician services focused on neonatal, maternal-fetal, pediatric cardiology and other pediatric subspecialty care across 37 states.
Why Are We Cautious About MD?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 1.3% annually over the last two years
- Smaller revenue base of $1.95 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 1.5%
At $27.10 per share, Pediatrix Medical Group trades at 11.5x forward P/E. To fully understand why you should be careful with MD, check out our full research report (it’s free).
One Stock to Watch:
WEX (WEX)
Trailing 12-Month Free Cash Flow Margin: 3.9%
Originally founded in 1983 as Wright Express to serve the fleet card market, WEX (NYSE:WEX) provides payment processing and business solutions across fleet management, employee benefits, and corporate payments sectors.
Why Could WEX Be a Winner?
- Performance over the past five years was boosted by share buybacks, which enabled its earnings per share to grow faster than its revenue
- ROE punches in at 18.2%, illustrating management’s expertise in identifying profitable investments
WEX is trading at $185.96 per share, or 9.2x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.